Eslicarbazepine acetate in the management of refractory bipolar disorder

Kamal Nath, Arnab Bhattacharya, Samir Kumar Praharaj

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

Original languageEnglish
Number of pages1
JournalClinical Neuropharmacology
Issue number6
Publication statusPublished - 01-11-2012

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)


Dive into the research topics of 'Eslicarbazepine acetate in the management of refractory bipolar disorder'. Together they form a unique fingerprint.

Cite this